Primary |
Dry Eye |
63.9% |
Product Used For Unknown Indication |
6.6% |
Blood Cholesterol |
3.3% |
Blood Cholesterol Increased |
3.3% |
Cardiac Disorder |
3.3% |
Drug Use For Unknown Indication |
3.3% |
Laceration |
3.3% |
Prophylaxis |
3.3% |
Dementia |
1.6% |
Epilepsy |
1.6% |
Eye Irritation |
1.6% |
Eye Pruritus |
1.6% |
Hypertension |
1.6% |
Neoplasm Malignant |
1.6% |
|
Vision Blurred |
13.3% |
Eye Discharge |
10.0% |
Eye Infection |
10.0% |
Corneal Abrasion |
6.7% |
Eye Pain |
6.7% |
Ocular Hyperaemia |
6.7% |
Activities Of Daily Living Impaired |
3.3% |
Blindness |
3.3% |
Conjunctivitis |
3.3% |
Eye Irritation |
3.3% |
Eye Swelling |
3.3% |
Heart Rate Increased |
3.3% |
Intraocular Pressure Increased |
3.3% |
Lip Swelling |
3.3% |
Mental Status Changes |
3.3% |
Photophobia |
3.3% |
Prostate Cancer |
3.3% |
Pruritus |
3.3% |
Scleral Hyperaemia |
3.3% |
Suicidal Ideation |
3.3% |
|
Secondary |
Dry Eye |
47.6% |
Eye Irritation |
18.3% |
Corneal Disorder |
14.6% |
Pain |
4.9% |
Product Used For Unknown Indication |
4.9% |
Glaucoma |
2.0% |
Blepharitis |
1.6% |
Postoperative Care |
1.2% |
Antibiotic Therapy |
0.8% |
Arthritis |
0.8% |
Eye Allergy |
0.8% |
Routine Health Maintenance |
0.8% |
Colitis Ulcerative |
0.4% |
Eye Pruritus |
0.4% |
Hormone Replacement Therapy |
0.4% |
Wrong Drug Administered |
0.4% |
|
Eye Irritation |
14.3% |
Eye Discharge |
11.9% |
Conjunctivitis |
7.1% |
Dry Eye |
7.1% |
Eyelid Injury |
7.1% |
Corneal Abrasion |
4.8% |
Eye Pain |
4.8% |
Facial Pain |
4.8% |
Ocular Hyperaemia |
4.8% |
Scleral Hyperaemia |
4.8% |
Skin Burning Sensation |
4.8% |
Vision Blurred |
4.8% |
Application Site Erythema |
2.4% |
Chest Pain |
2.4% |
Cutis Laxa |
2.4% |
Drug Ineffective |
2.4% |
Drug Interaction |
2.4% |
Eye Complication Associated With Device |
2.4% |
Eye Disorder |
2.4% |
Eye Infection |
2.4% |
|
Concomitant |
Dry Eye |
48.8% |
Product Used For Unknown Indication |
11.4% |
Drug Use For Unknown Indication |
10.1% |
Hypertension |
3.6% |
Glaucoma |
3.4% |
Asthma |
3.1% |
Chronic Obstructive Pulmonary Disease |
2.3% |
Growth Of Eyelashes |
2.3% |
Hypothyroidism |
1.6% |
Postoperative Care |
1.6% |
Carcinoid Tumour |
1.3% |
Diabetes Mellitus |
1.3% |
Dry Eyes |
1.3% |
Hyperlipidaemia |
1.3% |
Prophylaxis |
1.3% |
Anaemia |
1.0% |
Anxiety |
1.0% |
Blood Cholesterol Increased |
1.0% |
Increased Appetite |
1.0% |
Insomnia |
1.0% |
|
Eye Irritation |
18.6% |
Vision Blurred |
11.8% |
Ocular Hyperaemia |
10.8% |
Eye Pain |
5.9% |
Foreign Body Sensation In Eyes |
5.9% |
Dry Eye |
4.9% |
Eye Discharge |
4.9% |
Urinary Tract Infection |
4.9% |
Eye Pruritus |
3.9% |
Impaired Healing |
3.9% |
Drug Ineffective |
2.9% |
Fatigue |
2.9% |
Lacrimation Increased |
2.9% |
Wrist Fracture |
2.9% |
Wrong Technique In Drug Usage Process |
2.9% |
Application Site Pain |
2.0% |
Erythema Of Eyelid |
2.0% |
Headache |
2.0% |
Myocardial Infarction |
2.0% |
Urine Output Decreased |
2.0% |
|